Moderna Inc (MRNA) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $51.71
• Market Cap: $20.07B
• EPS: $-7.38
• 52-Week High: $55.20
• 52-Week Low: $22.28

Market Sentiment

Moderna Inc currently has a Neutral sentiment score of 0.12.

About Moderna Inc

Moderna, Inc. is a pioneering biotechnology company based in Cambridge, Massachusetts, recognized for its innovative approach to messenger RNA (mRNA) technology in vaccine and therapeutic development. Gaining global prominence for its role in delivering one of the first successful COVID-19 vaccines, Moderna is now strategically expanding its portfolio to target a wide array of health challenges, including immuno-oncology, rare diseases, cardiovascular conditions, and autoimmune disorders. Wit...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Moderna Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MRNA pay dividends?

Moderna Inc (MRNA) does not currently pay a regular dividend.

What is MRNA's market cap?

Moderna Inc (MRNA) has a market capitalization of $20.07B with a current stock price of $51.71.